Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Scientific Officer

June 18, 2021 at 12:00 AM EDT
Supporting Materials:

Pharming Group announces the appointment of Anurag Relan as Chief Medical Officer (CMO), effective immediately, and Robert Friesen as Chief Scientific Officer, effective from 1 August 2021.

Anurag and Robert will be the successors of Bruno Giannetti, who was Chief Operating Officer (2006 - 2019) and Chief Medical Officer from 2019. Bruno announced his retirement from the Executive Committee at Pharming’s recent Annual General Meeting of Shareholders, Bruno will stay with the company on a consultancy basis.